To the Editor

We read with interest the study by Johnsrud et al. The authors retrospectively examined outcomes in a cohort of patients with atrial fibrillation undergoing surgical left atrial appendage (LAA) exclusion during cardiac surgery. The authors aimed to evaluate the long‐term effect of LAA exclusion on oral anticoagulation (OAC) prescription and stroke. They evaluated 91 patients who, during surgery, underwent LAA exclusion, and matched them to patients who did not. The final analysis included only 62 pairs, matched on 16 pre‐treatment variables, and demonstrated no significant difference in OAC prescription and stroke at discharge and at 5 years.[1](#clc23149-bib-0001){ref-type="ref"}

We have concerns regarding the study design, its analysis, and conclusions. First, the single‐center nature of the study limits the generalizability of its results. Second, their study is underpowered to demonstrate an important difference between the two arms, which limits the credibility of any inferences, and is not appropriate to draw conclusions around safety and efficacy of LAA exclusion. We estimate that the odds ratio for stroke is 2.5 in the LAA exclusion group compared to control. As such, to accurately draw inferences around an odds ratio of 2.5, with 80% power and an event rate in the control arm of 4%, 318 matched pairs are required. If the event rate in the control group was 2.5%, consistent with conservative estimates, 490 pairs would be required.[2](#clc23149-bib-0002){ref-type="ref"} The lack of power in Johnsrud et al\'s study limits the credibility of their claim that their study calls into question the utility of empiric LAA closure. Third, the authors do not provide details regarding the technique used for LAA exclusion. This is important as the purse‐string closure achieves complete exclusion in only 43% of patients.[3](#clc23149-bib-0003){ref-type="ref"} Incomplete exclusion can result in increased blood stagnation and higher velocity at the appendage os; potentially increasing the risk of stroke. For LAA exclusion to be effective, occlusion must achieved. Intraoperative transesophageal echocardiography should be used to ensure complete occlusion.[4](#clc23149-bib-0004){ref-type="ref"}

Because of these major weaknesses, limited conclusions can be drawn from the study by Johnsrud et al. A multitude of small observational studies have been published on the safety and efficacy of LAA occlusion, yielding conflicting results. Only a large randomized controlled trial (RCT) can provide a definitive and unbiased answer regarding the efficacy and safety of concomitant LAA exclusion during cardiac surgery. Left Atrial Appendage Occlusion Study III (LAAOS III), an ongoing RCT of concomitant surgical LAA exclusion in patients with a history of atrial fibrillation, has recruited 4813 patients. After a median follow‐up of 4 years, LAAOS III will definitively tell us whether LAA exclusion should be routinely done with cardiac surgery in patients with atrial fibrillation.[2](#clc23149-bib-0002){ref-type="ref"}
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